Recruit-backed e-commerce fulfilment services provider ShipBob increased its total funding to more than $62m in a round led by Menlo Ventures.

GV led Benson Hill Biosystems' latest round, which increased the total raised by the crop specification technology provider to more than $94m.

BennuBio has assumed control of an existing UNM licence for cytometer technology, securing commitments from three investors to target a commercial release by next year.

Allied Minds has backed a series B round for its portfolio company BridgeSat, which also welcomed Boeing HorizonX Ventures as an investor.

Twentyeight-Seven Therapeutics has officially launched with $65m in series A funding to commercialise oncology treatments based on research at Harvard Medical School.

Novartis Venture Fund, a founding investor, co-led a $65m series A round to launch cancer treatment developer Twentyeight-Seven Therapeutics.

Evolution Media has put its weight behind MasterClass, an online education provider already backed by Bloomberg and Novel Group.

Tencent has led a $100m series D round for fantasy sports company Dream11, a deal that was first rumoured in April this year.

NIBC Bank has contributed to a $100m funding round for lender Acorn OakNorth, which is now valued at $2.3bn.

Guardant Health is targeting $100m in proceeds for its initial public offering on the Nasdaq Global Select Market, which would offer an exit to SoftBank.